Cyclic Interf eron Alpha Treatment in Metastatic Renal Cell Carcinoma: Results of a Phase II Study and Review of the Literature
Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma
2006 ◽
Vol 24
(6)
◽
pp. 487-491
◽
Keyword(s):
Phase Ii
◽